These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 32875686)

  • 21. Risks and Benefits of Attention-Deficit/Hyperactivity Disorder Medication on Behavioral and Neuropsychiatric Outcomes: A Qualitative Review of Pharmacoepidemiology Studies Using Linked Prescription Databases.
    Chang Z; Ghirardi L; Quinn PD; Asherson P; D'Onofrio BM; Larsson H
    Biol Psychiatry; 2019 Sep; 86(5):335-343. PubMed ID: 31155139
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stimulant treatment of ADHD and cigarette smoking: a meta-analysis.
    Schoenfelder EN; Faraone SV; Kollins SH
    Pediatrics; 2014 Jun; 133(6):1070-80. PubMed ID: 24819571
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association Between Medication Use for Attention-Deficit/Hyperactivity Disorder and Risk of Motor Vehicle Crashes.
    Chang Z; Quinn PD; Hur K; Gibbons RD; Sjölander A; Larsson H; D'Onofrio BM
    JAMA Psychiatry; 2017 Jun; 74(6):597-603. PubMed ID: 28492937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes.
    Faraone SV; Glatt SJ
    J Clin Psychiatry; 2010 Jun; 71(6):754-63. PubMed ID: 20051220
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk of Suicidal Events With Atomoxetine Compared to Stimulant Treatment: A Cohort Study.
    Linden S; Bussing R; Kubilis P; Gerhard T; Segal R; Shuster JJ; Winterstein AG
    Pediatrics; 2016 May; 137(5):. PubMed ID: 27244795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature.
    Wilens TE; Faraone SV; Biederman J; Gunawardene S
    Pediatrics; 2003 Jan; 111(1):179-85. PubMed ID: 12509574
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between medication prescription for atopic diseases and attention-deficit/hyperactivity disorder.
    van der Schans J; Pleiter JC; de Vries TW; Schuiling-Veninga CC; Bos JH; Hoekstra PJ; Hak E
    Ann Allergy Asthma Immunol; 2016 Aug; 117(2):186-91. PubMed ID: 27315741
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of prior stimulant treatment for attention-deficit/hyperactivity disorder on subsequent risk for cigarette smoking and alcohol and drug use disorders in adolescents.
    Wilens TE; Adamson J; Monuteaux MC; Faraone SV; Schillinger M; Westerberg D; Biederman J
    Arch Pediatr Adolesc Med; 2008 Oct; 162(10):916-21. PubMed ID: 18838643
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association.
    Goldman LS; Genel M; Bezman RJ; Slanetz PJ
    JAMA; 1998 Apr; 279(14):1100-7. PubMed ID: 9546570
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of symptoms of attention deficit-hyperactivity disorder and impulsive-aggression with severity of suicidal behavior in adult attempters.
    Conejero I; Jaussent I; Lopez R; Guillaume S; Olié E; Hebbache C; Cohen RF; Kahn JP; Leboyer M; Courtet P; Lopez-Castroman J
    Sci Rep; 2019 Mar; 9(1):4593. PubMed ID: 30872743
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: A systematic review with network meta-analyses of randomised trials.
    Catalá-López F; Hutton B; Núñez-Beltrán A; Page MJ; Ridao M; Macías Saint-Gerons D; Catalá MA; Tabarés-Seisdedos R; Moher D
    PLoS One; 2017; 12(7):e0180355. PubMed ID: 28700715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vitamin D Status and Attention Deficit Hyperactivity Disorder: A Systematic Review and Meta-Analysis of Observational Studies.
    Khoshbakht Y; Bidaki R; Salehi-Abargouei A
    Adv Nutr; 2018 Jan; 9(1):9-20. PubMed ID: 29438455
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Callous-unemotional traits, proactive aggression, and treatment outcomes of aggressive children with attention-deficit/hyperactivity disorder.
    Blader JC; Pliszka SR; Kafantaris V; Foley CA; Crowell JA; Carlson GA; Sauder CL; Margulies DM; Sinha C; Sverd J; Matthews TL; Bailey BY; Daviss WB
    J Am Acad Child Adolesc Psychiatry; 2013 Dec; 52(12):1281-93. PubMed ID: 24290461
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ADHD Medication and Substance-Related Problems.
    Quinn PD; Chang Z; Hur K; Gibbons RD; Lahey BB; Rickert ME; Sjölander A; Lichtenstein P; Larsson H; D'Onofrio BM
    Am J Psychiatry; 2017 Sep; 174(9):877-885. PubMed ID: 28659039
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of pharmacotherapy for attention deficit hyperactivity disorder on risk of seizures in pediatric patients as assessed in an insurance claims database.
    McAfee AT; Holdridge KC; Johannes CB; Hornbuckle K; Walker AM
    Curr Drug Saf; 2008 May; 3(2):123-31. PubMed ID: 18690990
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mortality associated with attention-deficit hyperactivity disorder (ADHD) drug treatment: a retrospective cohort study of children, adolescents and young adults using the general practice research database.
    McCarthy S; Cranswick N; Potts L; Taylor E; Wong IC
    Drug Saf; 2009; 32(11):1089-96. PubMed ID: 19810780
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Possible association between attention deficit hyperactivity disorder and attempted suicide in adolescents - a pilot study.
    Manor I; Gutnik I; Ben-Dor DH; Apter A; Sever J; Tyano S; Weizman A; Zalsman G
    Eur Psychiatry; 2010 Apr; 25(3):146-50. PubMed ID: 19699060
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Age of Onset, Duration, and Type of Medication Therapy for Attention-Deficit/Hyperactivity Disorder and Substance Use During Adolescence: A Multi-Cohort National Study.
    McCabe SE; Dickinson K; West BT; Wilens TE
    J Am Acad Child Adolesc Psychiatry; 2016 Jun; 55(6):479-86. PubMed ID: 27238066
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Attention-deficit/hyperactivity disorder symptoms and suicidal behavior in adult psychiatric outpatients.
    Stickley A; Tachimori H; Inoue Y; Shinkai T; Yoshimura R; Nakamura J; Morita G; Nishii S; Tokutsu Y; Otsuka Y; Egashira K; Inoue M; Kubo T; Tesen H; Takashima N; Tominaga H; Koyanagi A; Kamio Y
    Psychiatry Clin Neurosci; 2018 Sep; 72(9):713-722. PubMed ID: 29845681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative efficacy and safety of methylphenidate and atomoxetine for attention-deficit hyperactivity disorder in children and adolescents: Meta-analysis based on head-to-head trials.
    Liu Q; Zhang H; Fang Q; Qin L
    J Clin Exp Neuropsychol; 2017 Nov; 39(9):854-865. PubMed ID: 28052720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.